FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM

K Number: K820192 · Decision Mar 11, 1982
Classifications
1
FEI Numbers
6
Registration Numbers
6
Same Product Code
5
Applicant Total
44
Review Days
45

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM
K Number
K820192
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.3300
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Applicant
Hyland Therapeutic Div., Travenol Laboratories
Date Received
January 25, 1982
Decision Date
March 11, 1982
Product Code
GRP
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
GRP Antisera, All Types, H. Influenza

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (GRP), ordered by most recent decision date.

View all

Other Clearances by Hyland Therapeutic Div., Travenol Laboratories

K Number Device Name
K820835 ALUMINA SILICA-ACTIVATED PARTIAL THROM
K812220 NEPHELOMETRIC SOLID TURBIDITY STANDARD
K810078 Q-PAK THERAPEUTIC DRUG MONIT. CONTROL S
K810077 OMEGA THERAPEUTIC DRUG MONIT. CONTROL S.
K802610 ALERT A,HDL-APOLIPOROTEIN A, TEST KIT
K791113 LOW IONIC STRENGTH SOLUTION (LISS)
K790249 TEST CELLS
K781225 GLOBULIN TEST, HUMAN THYROXINE BINDING
K780962 AUTOMATED ENZYME
K780785 DILUTOR TRANSPORTER
Search all 44 clearances from Hyland Therapeutic Div., Travenol Laboratories →